Sort
85,873 grants matching “alzheimers”
Peripheral Tissue Biomarker for Premortem Diagnosis of Lewy Body Dementia
$1,090,231Shu G Chen · University Of Alabama At Birmingham · R01 · FY2025 · NS
Neurobiology of Mild Cognitive Impairment
$1,090,150Elliott Jay Mufson · St. Joseph'S Hospital And Medical Center · P01 · FY2014 · AG
Development of Cdk5 Inhibitors
$1,090,050Kenneth S Kosik · University Of California Santa Barbara · U01 · FY2009 · AG
Shared resource to develop tools and reagents to study structural polymorphisms in Abeta amyloid aggregates in AD
$1,089,558Charles G Glabe · University Of California-Irvine · U24 · FY2023 · AG
Prediction of Psychosis in Alzheimer Disease
$1,089,531Robert A Sweet · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AG
A Haplotype Map for Multiple Sclerosis
$1,089,455Stephen L Hauser · University Of California, San Francisco · R01 · FY2010 · NS
Developing an Elderly Patient-Specific, Accurate, Intuitive and Highly Interpretable System for Unconsciousness Management in General Anesthesia Using PASCALL FDA-Cleared Intraoperative EEG Monitor
$1,089,346Tuan Le Mau · Pascall Systems, Incorporated · R44 · FY2025 · AG
Shared resource to develop tools and reagents to study structural polymorphisms in Abeta amyloid aggregates in AD
$1,089,279Charles G Glabe · University Of California-Irvine · U24 · FY2024 · AG
Shared resource to develop tools and reagents to study structural polymorphisms in Abeta amyloid aggregates in AD
$1,089,279Charles G Glabe · University Of California-Irvine · U24 · FY2025 · AG
The Arabidopsis Transcription Factor ORFeome and downstream genomic application
$1,089,150Steve A Kay · University Of California, San Diego · RC2 · FY2009 · GM
Neurostimulation and Recording of Real World Spatial Navigation in Humans
$1,089,050Nanthia A Suthana · University Of California Los Angeles · U01 · FY2020 · NS
Phase 2 Enabling Studies of a Candidate Drug Therapy (T3D-959) Regulating Neurometabolism for the Treatment of Huntington's Disease
$1,088,768John Didsbury · T3d Therapeutics, Inc. · R44 · FY2022 · NS
BIOLOGY OF ALZHEIMERS DISEASE IN TRANSGENIC MICE
$1,087,686University Of Minnesota Twin Cities · P01 · FY2001 · AG
Dysfunctional lipid metabolism and peroxidation in chronic pain and neurodegeneration
$1,087,313Christopher Ramsden · National Institute On Aging · ZIA · FY2019 · AG
Administrative Core
$1,087,048Helena Chang Chui · University Of Southern California · P30 · FY2025 · AG
Alzheimer's Disease Patient Registry (ADPR)
$1,086,625Group Health Cooperative · U01 · FY2004 · AG
Proof-of-Concept Trial of an Alpha-7 Nicotinic Agonist for Nicotine Dependence
$1,086,478A Eden Evins · Massachusetts General Hospital · R01 · FY2015 · DA
Role of Neurotrophins and Their Receptors in the Development of the Mammalian Ne
$1,086,465Lino Tessarollo · Basic Sciences · Z01 · FY2007 · CA
ALZHEIMERS RESEARCH PROJECT: Developing Extraceullar Vesicle biomarkers for clinical and preclinical AD/ADRD
$1,086,297Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2025 · AG
ALZHEIMERS RESEARCH PROJECT / CLINICAL PROJECT: Mechanistic and clinical studies in Alzheimer's disease and related disorders
$1,086,297Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2025 · AG
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)
$1,086,202Michael D Geschwind · University Of California, San Francisco · R01 · FY2023 · AG
Novel Early Retinal Imaging Biomarkers for Treating Later Spatial Memory Loss in Experimental Alzheimer's Disease
$1,086,200Bruce A. Berkowitz · Wayne State University · R01 · FY2024 · AG
Develop GABAergic Neuron Protectors for Treating ApoE4-Related Alzheimer's Disease
$1,086,082Robert W. Mahley · Gabaeron, Inc. · R44 · FY2021 · AG
Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's Disease
$1,086,079John Joseph Sninsky · Superfluid Dx, Inc. · R44 · FY2023 · AG
Clinical Core
$1,086,072Robert A Sweet · University Of Pittsburgh At Pittsburgh · P30 · FY2023 · AG